Apotea AB (publ) (CHIX:APOTES) Loans Receivable: kr0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:APOTES Apotea AB (publ) CHIX:APOTES
18 GF Score
Price kr65.20
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Loans Receivable?

Apotea AB (publ) CHIX:APOTES 18 Loans Receivable is kr0 Mil as of Jun. 2026. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Apotea AB (publ)'s Loans Receivable for the quarter that ended in Jun. 2026 was kr0 Mil.

Apotea AB (publ) Loans Receivable Related Terms

Apotea AB (publ) Loans Receivable Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Loans Receivable Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
0.00 0.00 0.00 0.00 0.00

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:APOTES
18GF Score
Apotea AB (publ) CHIX:APOTES
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of kr0 Mil mean?
Apotea AB (publ) (CHIX:APOTES) has a Loans Receivable of kr0 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s Loans Receivable too high?
Apotea AB (publ)'s current Loans Receivable is kr0 Mil. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Loans Receivable compare to competitors?
Apotea AB (publ)'s Loans Receivable of kr0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Healthcare Providers & Services company?
A good Loans Receivable depends on the Healthcare Providers & Services industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Apotea AB (publ) and its competitors. Apotea AB (publ)'s current Loans Receivable is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current Loans Receivable of kr0 Mil. The current Loans Receivable is kr0 Mil. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current Loans Receivable is kr0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score

Get the complete analysis for CHIX:APOTES

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr65.20
Price